Cargando…

MAPK13 stabilization via m(6)A mRNA modification limits anticancer efficacy of rapamycin

N(6)-adenosine methylation (m(6)A) is the most abundant mRNA modification that controls gene expression through diverse mechanisms. Accordingly, m(6)A-dependent regulation of oncogenes and tumor suppressors contributes to tumor development. However, the role of m(6)A-mediated gene regulation upon dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Joohwan, Chun, Yujin, Ramirez, Cuauhtemoc B., Hoffner, Lauren A., Jung, Sunhee, Jang, Ki-Hong, Rubtsova, Varvara I., Jang, Cholsoon, Lee, Gina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511813/ https://www.ncbi.nlm.nih.gov/pubmed/37599001 http://dx.doi.org/10.1016/j.jbc.2023.105175

Ejemplares similares

Quantitative analysis of m(6)A RNA modification by LC-MS
por: Mathur, Lavina, et al.
Publicado: (2021)

Metabolic Control of m(6)A RNA Modification
por: Kim, Joohwan, et al.
Publicado: (2021)

Destabilization of TNF-α mRNA by Rapamycin
por: Park, Jong-Woo, et al.
Publicado: (2012)

The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes
por: Lisi, Lucia, et al.
Publicado: (2011)

An approach to analyse the specific impact of rapamycin on mRNA-ribosome association
por: Genolet, Raphael, et al.
Publicado: (2008)

New mRNA modification?
por: Leslie, Mitch
Publicado: (2007)

The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease
por: Park, Grace, et al.
Publicado: (2021)

Limited effects of m(6)A modification on mRNA partitioning into stress granules
por: Khong, Anthony, et al.
Publicado: (2022)

The emerging role of RNA modifications in the regulation of mRNA stability
por: Boo, Sung Ho, et al.
Publicado: (2020)

Analysis of mRNA m(6)A modification and mRNA expression profiles in middle ear cholesteatoma
por: Xie, Shumin, et al.
Publicado: (2023)

In search of the mRNA modification landscape in plants
por: Chmielowska-Bąk, Jagna, et al.
Publicado: (2019)

RNA modification in mRNA cancer vaccines
por: Mei, Yingxue, et al.
Publicado: (2023)

Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency
por: Kim, Sun Chang, et al.
Publicado: (2021)

LKB1 induces apical trafficking of Silnoon, a monocarboxylate transporter, in Drosophila melanogaster
por: Jang, Cholsoon, et al.
Publicado: (2008)

Dynamic regulation and functions of mRNA m6A modification
por: Wang, Shanshan, et al.
Publicado: (2022)

Modulation of translational decoding by m(6)A modification of mRNA
por: Jain, Sakshi, et al.
Publicado: (2023)

Crosstalk between Edc4 and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in mRNA Decapping
por: Rahman, Hazir, et al.
Publicado: (2014)

Aberrant Regulation of mRNA m(6)A Modification in Cancer Development
por: Luo, Junyun, et al.
Publicado: (2018)

Diverse molecular functions of m(6)A mRNA modification in cancer
por: Han, Seung Hun, et al.
Publicado: (2020)

mRNA modifications: Dynamic regulators of gene expression?
por: Hoernes, Thomas Philipp, et al.
Publicado: (2016)

Control of mRNA translation by dynamic ribosome modification
por: Grenga, Lucia, et al.
Publicado: (2020)

New Twists in Detecting mRNA Modification Dynamics
por: Anreiter, Ina, et al.
Publicado: (2021)

RNAmod: an integrated system for the annotation of mRNA modifications
por: Liu, Qi, et al.
Publicado: (2019)

Interplays of different types of epitranscriptomic mRNA modifications
por: Rengaraj, Praveenkumar, et al.
Publicado: (2021)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
por: Liu, Albert, et al.
Publicado: (2022)

Chemical Modifications of mRNA Ends for Therapeutic Applications
por: Warminski, Marcin, et al.
Publicado: (2023)

Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN
por: Cao, Yuhan, et al.
Publicado: (2019)

m(6)A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover
por: Ke, Shengdong, et al.
Publicado: (2017)

m(6)A in the Signal Transduction Network
por: Jang, Ki-Hong, et al.
Publicado: (2022)

Lactobacillus paracasei treatment modulates mRNA expression in macrophages
por: Han, Dae Hee, et al.
Publicado: (2020)

Dynamic m(6)A modification regulates local translation of mRNA in axons
por: Yu, Jun, et al.
Publicado: (2018)

The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice
por: Hartman, Adam L., et al.
Publicado: (2012)

Picornavirus Modification of a Host mRNA Decay Protein
por: Rozovics, Janet M., et al.
Publicado: (2012)

mRNA structure determines modification by pseudouridine synthase 1
por: Carlile, Thomas M., et al.
Publicado: (2019)

Opportunities and Challenges to Profile mRNA Modifications in Escherichia coli
por: Petrov, Dimitar Plamenov, et al.
Publicado: (2022)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018)

Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor
por: Artoni, Filippo, et al.
Publicado: (2023)

Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
por: Luo, Yan, et al.
Publicado: (2015)

FMRP Enhances the Translation of 4EBP2 mRNA during Neuronal Differentiation
por: Yu, Jinbae, et al.
Publicado: (2023)

Sex-dependent effects of multiple acute concurrent stresses on memory: a role for hippocampal estrogens
por: Hokenson, Rachael E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9o6jnlc6vq5u5s0sje4tr77k2h